NICOLE BAROSSI: Open Payments
NPI 1316243322 · CAPE MAY COURT HOUSE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 17 payments from 10 companies in 2025. Trend: 2023 $497 · 2024 $267 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $87 |
| Alnylam Pharmaceuticals Inc. | 3 | $76 |
| Amgen Inc. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| HEARTFLOW, INC. | 1 | $31 |
| Boston Scientific Corporation | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Abbott Laboratories | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: VYNDAQEL, ONPATTRO, REPATHA, LEQVIO, FFRct, WATCHMAN FLX, AMVUTTRA, CARDIOMEMS.
Industry payments across NJ — which companies pay providers there.
